Pathophysiology, Genetics & Classification

Question	Answer
1. What is the fundamental molecular defect and genetic predisposition underpinning the immunopathogenesis of celiac disease?	Celiac disease is driven by an immune-mediated enteropathy triggered by dietary gluten in genetically susceptible individuals carrying Human Leukocyte Antigen class II alleles HLA-DQ2 (encoded by DQA1star0501 and DQB1star0201) or HLA-DQ8 (encoded by DQA1star0301 and DQB1star0302).
2. What is the precise biochemical role of tissue transglutaminase (tTG-2) in the deamidation of gluten peptides?	Extracellular tTG-2 converts neutral, uncharged glutamine residues in gliadin peptides into negatively charged glutamic acid residues through deamidation, introducing a net negative charge that dramatically enhances binding affinity to the positively charged antigen-binding pockets of HLA-DQ2/DQ8 molecules on antigen-presenting cells.
3. How do HLA-DQ2 and HLA-DQ8 molecules structurally facilitate the presentation of deamidated gliadin peptides to mucosal T-cells?	The peptide-binding grooves of HLA-DQ2 and HLA-DQ8 possess basic, positively charged amino acid residues at specific anchor pockets (P4, P6, P7, P9) that electrostatically attract and anchor the newly introduced negative carboxyl groups of deamidated gliadin peptides with high affinity.
4. What is the sequence of events leading from lamina propria CD4+ T-cell activation to mucosal destruction in celiac disease?	Antigen-presenting cells present deamidated gliadin via HLA-DQ2/DQ8 to lamina propria CD4+ T-cells, triggering a Th1 response characterized by massive secretion of pro-inflammatory cytokines, predominantly Interferon-gamma (IFN-gamma) and Tumor Necrosis Factor-alpha, which drive chronic inflammation and crypt hyperplasia.
5. What is the distinct role of intraepithelial lymphocytes (IELs) and enterocytes in the innate immune activation pathway of celiac disease?	In addition to adaptive immunity, toxic unmodified gliadin fragments (such as the 33-mer peptide) directly stimulate enterocytes to upregulate Interleukin-15 (IL-15), which programs intraepithelial CD8+ cytotoxic T-lymphocytes and NK cells to upregulate NKG2D receptors, leading to direct cytotoxicity and apoptosis of surface enterocytes via perforin-granzyme pathways.
6. What is the gold-standard histological classification system used worldwide to grade the duodenal mucosal lesions of celiac disease?	The Marsh-Oberhuber Classification (modified Marsh classification), which stratifies mucosal pathology from Stage 0 (normal) through Stage 1 (infiltrative), Stage 2 (hyperplastic), to Stage 3 (destructive, subdivided into 3a partial, 3b subtotal, and 3c total villous atrophy).
7. Describe the distinct histological features that characterize a Marsh Type 1 (Infiltrative) duodenal biopsy lesion.	Marsh Type 1 exhibits a normal mucosal architecture with preserved villus-to-crypt architecture, but features a marked increase in intraepithelial lymphocytes—defined as greater than 25 intraepithelial lymphocytes per 100 enterocytes (ESPGHAN 2020 criteria).
8. What are the key histological hallmarks of a Marsh Type 3c mucosal lesion in classical celiac disease?	Marsh Type 3c is characterized by total villous atrophy (complete absence or flattening of mucosal villi), profound crypt hyperplasia with elongated and branching crypts, and a dense lamina propria inflammatory infiltrate.
9. How does the crypt-to-villus ratio and enterocyte morphology alter across the spectrum of Marsh classification stages?	Early stages (Marsh 1–2) preserve villi with crypt elongation, whereas advanced stages (Marsh 3) show progressive blunting and flattening of villi accompanied by a shift of enterocytes from tall columnar absorptive cells to cuboidal, mucin-depleted, mitotically hyperactive cells.
10. What specific anatomical region of the gastrointestinal tract bears the brunt of gluten-induced enteropathy and why?	The proximal small intestine (duodenum and proximal jejunum) bears the maximal histological damage because it is exposed to the highest luminal concentrations of ingested gluten peptides and possesses the highest density of tTG-2 enzyme activity.
11. What is the precise immunogenetic inheritance pattern of celiac disease, and what is the clinical negative predictive value of HLA testing?	Celiac disease follows a complex polygenic autosomal inheritance pattern; HLA-DQ2 and HLA-DQ8 testing has a negative predictive value approaching 99%, meaning the absence of both HLA-DQ2 and HLA-DQ8 effectively rules out celiac disease.
12. VIVA TRAP: A 6-year-old child with suspected celiac disease tests negative for HLA-DQ2 and HLA-DQ8. Can you completely rule out celiac disease?	YES. Due to the exceptionally high negative predictive value (>99%) of HLA-DQ2 and HLA-DQ8, a negative test reliably excludes the diagnosis of celiac disease in clinical practice.
13. What percentage of the general population carries HLA-DQ2 or HLA-DQ8 alleles, and what does this signify regarding their diagnostic utility?	Approximately 30% to 40% of the general European and Indian population carry HLA-DQ2 or HLA-DQ8, meaning these alleles have a high sensitivity but very low positive predictive value; thus, HLA typing is useful only to rule out the disease, not to establish a positive diagnosis.
14. Explain the cellular mechanism by which intraepithelial lymphocytes cause epithelial cell apoptosis independent of conventional antigen presentation.	IL-15 overexpression by enterocytes induces CD8+ intraepithelial lymphocytes to express killer cell lectin-like receptors (such as NKG2D), which bind to stress-induced ligands (MICA/MICB) upregulated on adjacent enterocytes, resulting in contact-dependent target cell lysis without peptide-MHC restriction.
15. How does small bowel mucosal damage lead to secondary mucosal lactase deficiency in untreated celiac disease?	Destruction and blunting of the villous tip enterocytes—where mature brush-border disaccharidases like lactase are exclusively localized—result in severe enzyme deficiency, causing secondary osmotic lactose intolerance and infantile osmotic diarrhea.
16. VIVA TRAP: Can a patient with Marsh Stage 0 mucosal histology have active, symptomatic celiac disease?	NEVER. By definition, active celiac disease requires an abnormal small intestinal mucosal pathology of at least Marsh Stage 1 (increased intraepithelial lymphocytes >25/100 enterocytes) in the presence of circulating disease-specific autoantibodies.
17. What is the role of fibroblast-like cells and extracellular matrix remodeling in creating crypt hyperplasia during Marsh Stage 2/3 lesions?	Subepithelial myofibroblasts and lamina propria fibroblasts secrete matrix metalloproteinases (MMPs) and growth factors under cytokine stimulation (TGF-beta and IL-1), driving rapid crypt cell proliferation and extracellular matrix degradation to compensate for surface enterocyte loss.
18. Differentiate between potential celiac disease and active celiac disease regarding serology and small bowel histology.	Potential celiac disease is defined by the presence of positive celiac serology (anti-tTG IgA / EMA IgA) and positive genetic markers (HLA-DQ2/DQ8) alongside a normal small bowel mucosa (Marsh 0), whereas active celiac disease demonstrates both positive serology and abnormal mucosal histology (Marsh 1–3).
19. VIVA TRAP: Does dietary gluten withdrawal instantly normalize lamina propria CD4+ T-cell infiltration and duodenal mucosal architecture?	NO. While intraepithelial lymphocytes and serological titers decline within weeks to months following gluten-free diet initiation, complete normalization of duodenal mucosal architecture (villus restitution and crypt height normalization) typically requires 6 to 24 months in children.

Clinical History & Bedside Evaluation

Question	Answer
1. What is the classic chronological age window of symptom onset in pediatric celiac disease, and how does the timing of gluten introduction influence it?	Symptoms typically manifest between 6 to 24 months of age, closely following the weaning period when wheat-based cereals (porridge, biscuits, or chapati) are introduced into the infant diet after months of exclusive breastfeeding.
2. How does the clinical presentation of celiac disease in toddlers under 2 years differ fundamentally from that seen in older children and adolescents?	Toddlers predominantly present with the classical malabsorption triad of chronic pale bulky steatorrhea, marked abdominal distension with wasting of the proximal limbs and gluteal muscles, and arrested linear growth, whereas older children usually exhibit non-classical or atypical presentations like short stature or isolated anemia.
3. What specific features in a dietary recall history point toward an unrecognized high gluten load versus occult cross-contamination in a deteriorating celiac child?	A high gluten load is indicated by the regular consumption of overt forbidden grains like wheat, barley, or rye (BROW), whereas occult cross-contamination is revealed through shared toasters, use of commercially processed foods lacking gluten-free certification, or dining at restaurants with poor segregation practices.
4. In evaluating a child with chronic diarrhea and failure to thrive, what perinatal and early developmental red flags help distinguish celiac disease from congenital enteropathies?	Celiac disease characteristically features a normal birth weight, uneventful perinatal period, and normal early infancy development up until the introduction of dietary gluten, whereas congenital enteropathies present with profuse secretory diarrhea from the first days of life.
5. How should a structured family pedigree be constructed when evaluating a pediatric index case for celiac disease, and what is the expected sibling risk?	The pedigree must screen all first-degree relatives (parents, full siblings) for autoimmune disorders and silent celiac disease, as first-degree relatives carry a high genetic risk with an approximate 10% to 15% prevalence of biopsy-proven celiac disease.
6. What are the key differential diagnostic red flags in a malabsorption history that strongly argue against celiac disease and point toward cystic fibrosis?	A history of meconium ileus in the neonatal period, recurrent lower respiratory tract infections with chronic purulent cough, and foul-smelling greasy stools starting in early infancy point directly toward cystic fibrosis rather than celiac disease.
7. How does a history of exclusive breastfeeding duration impact the natural history and clinical timing of celiac disease presentation in susceptible infants?	Prolonged breastfeeding, especially when continued during the gradual introduction of dietary gluten, is associated with a delayed onset of symptoms and a blunted or milder presentation of celiac enteropathy in early childhood.
8. What bedside physical examination findings distinguish the muscle wasting of untreated celiac disease from protein-energy malnutrition (kwashiorkor)?	Celiac disease characteristically demonstrates prominent global wasting of the proximal muscle girdles and gluteal folds (potbelly appearance due to hypotonia and gas distension) without the dependent pedal edema, skin depigmentation, or psychomotor apathy characteristic of kwashiorkor.
9. What specific extra-intestinal bedside examination findings provide crucial diagnostic clues for chronic fat-soluble malabsorption in a child with growth failure?	Look for signs of rickets (craniotabes, widened wrists, rachitic rosary) due to Vitamin D malabsorption, easy bruising or petechiae (Vitamin K deficiency), night blindness (Vitamin A deficiency), or peripheral neuropathy and ataxia (Vitamin E deficiency).
10. What clinical history elements in a school-aged child with refractory iron deficiency anemia should immediately raise suspicion of atypical celiac disease?	The presence of persistent microcytic anemia refractory to adequate courses of oral iron supplementation, especially when accompanied by recurrent painful aphthous stomatitis, dental enamel hypoplasia of permanent incisors, or unexplained chronic fatigue.
11. How does the pattern of abdominal distension and bowel sounds observed during bedside clinical examination differ between active celiac disease and small bowel bacterial overgrowth?	Active celiac disease typically presents with a doughy or fluid-filled, painless abdominal distension with normal or sluggish bowel sounds, whereas small bowel bacterial overgrowth often presents with tympanitic, gas-filled distension and hyperactive borborygmi.
12. VIVA TRAP: A 5-year-old child presents with chronic diarrhea and weight loss, and the mother reports that the child's symptoms completely resolved for three months after a brief course of antibiotics. Does this history exclude celiac disease?	NO. Temporary symptomatic improvement with antibiotics can occur due to treatment of secondary small bowel bacterial overgrowth or coincidental viral gastroenteritis, which frequently complicates untreated celiac disease.
13. What specific historical details in an adolescent presenting with delayed puberty or short stature should prompt screening for celiac disease?	A history of progressive deceleration along the height percentile curves starting in early childhood, delayed bone age, and a complete absence of secondary sexual characteristics by age 13 in girls or 14 in boys, independent of gastrointestinal symptoms.
14. How does the clinical history of stool character in celiac disease differ from that of inflammatory bowel disease (Crohn's disease)?	Celiac stools are classically pale, voluminous, greasy, foul-smelling, and float in water due to steatorrhea, whereas Crohn's disease stools are typically watery or semi-formed and frequently mixed with visible macroscopic blood and mucus, accompanied by tenesmus and colicky abdominal pain.
15. What predisposing autoimmune and genetic risk factors must be actively inquired about in the clinical history of a child evaluated for chronic malabsorption?	The clinician must specifically ask about a personal or family history of Type 1 Diabetes Mellitus, Autoimmune Thyroiditis (Hashimoto's), Down syndrome, Turner syndrome, Williams syndrome, and Selective IgA Deficiency.
16. VIVA TRAP: A mother states her child has been eating a strict gluten-free diet for the past two weeks because of abdominal pain, and her anti-tTG IgA is markedly elevated. Can you make a definitive diagnosis of celiac disease based on this history?	NO. Initiating a gluten-free diet prior to diagnostic testing can rapidly reduce antibody titers and cause mucosal healing, making antibody interpretation and duodenal biopsy staging unreliable; gluten must be present in the daily diet for at least 6 weeks before serological and histological assessment.
17. What bedside clinical signs in a young infant indicate the life-threatening entity known as 'celiac crisis'?	Profound lethargy, severe abdominal distension with painful tympany, generalized edema (anasarca) due to severe hypoalbuminemia, signs of dehydration, and carpopedal spasm secondary to hypocalcemic tetany.
18. How does the history of dental development in children with early-onset celiac disease manifest during a routine oral inspection?	Symmetrical, chronological enamel defects affecting the permanent teeth (especially incisors and first molars)—manifesting as color changes (yellow-brown) or structural pitting and grooves—which reflect systemic ameloblast injury during tooth formation.
19. What specific nutritional intake history should be elicited when a child with known celiac disease on a gluten-free diet presents with persistent fatigue and microcytic anemia?	Inquiry must focus on the accidental ingestion of hidden gluten sources (malt flavoring, soy sauce, processed condiments) and whether the gluten-free substitute grains being consumed are adequately fortified with iron and B-complex vitamins.
20. VIVA TRAP: A 3-year-old child with classical celiac symptoms has a history of exclusive formula feeding since birth without any history of breastfeeding or early cow's milk exposure. Does this rule out the diagnosis?	NONE. Exclusive formula feeding with standard cow's milk-based formulas containing no gluten does not protect against or cause celiac disease; symptom onset is strictly determined by the chronological introduction of gluten-containing grains (wheat, barley, rye) into the weaning diet.

Physical Examination & Bedside Signs

Question	Answer
1. What specific inspection findings are visible in the oral cavity that serve as a strong clinical marker of underlying celiac disease?	1. Symmetrical, chronological enamel defects affecting the permanent incisors and first molars (grades I to IV according to Aine's classification). 2. Recurrent, painful aphthous stomatitis scattered across the buccal mucosa and tongue.
2. How do you elicit and interpret the physical signs of severe protein-energy malnutrition and muscle wasting in the extremities during inspection?	1. Observe for marked wasting of the quadriceps, gastrocnemius, and shoulder girdle muscles. 2. Palpate the muscle bulk to confirm generalized hypotonia and diminished muscle mass resulting from chronic malabsorption and amino acid deprivation.
3. What specific bedside physical signs indicate severe fat-soluble vitamin malabsorption (Vitamin A, D, E, K) during systemic examination?	1. Dry, scaly skin with follicular hyperkeratosis (phrynoderma) indicating Vitamin A deficiency. 2. Easy bruising or petechiae due to prolonged prothrombin time from Vitamin K malabsorption.
4. How do you clinically examine for skeletal manifestations of rickets secondary to osteomalacia in a chronic malabsorbing celiac child?	1. Inspect and palpate for wrist widening (metaphyseal flaring), costochondral junctions ('rachitic rosary'), and bowing of the lower extremities (genu varum or valgum). 2. Assess for frontal bossing and delayed closure of the anterior fontanelle in younger toddlers.
5. What bedside sign demonstrates peripheral edema in a severely malnourished celiac child, and what is its underlying pathophysiological mechanism?	1. Bilateral, pitting pedal edema elicited by sustained thumb pressure over the medial malleolus for at least 5 seconds. 2. Caused by severe hypoalbuminemia resulting from protein-losing enteropathy and depressed hepatic synthesis.
6. How does inspection of the palmar creases and nail beds assist in assessing the severity of chronic malabsorptive anemia at the bedside?	1. Inspection reveals profound pallor of the palmar creases (worsened when creases are hypopigmented compared to surrounding skin) and nail beds. 2. Look for koilonychia (spooning of the nails) reflecting long-standing iron deficiency secondary to proximal duodenal malabsorption.
7. What specific inspection finding involving the tongue can be detected during the oral examination of a child with celiac-related micronutrient deficiency?	Atrophic glossitis characterized by a smooth, red, 'beefy' or shiny tongue due to mucosal atrophy caused by iron, folate, or Vitamin B12 deficiency.
8. How do you perform a thorough cutaneous inspection for dermatitis herpetiformis, the cutaneous manifestation of celiac disease?	1. Inspect symmetrically distributed, intensely pruritic clusters of erythematous papules, urticarial plaques, and small vesicles over extensor surfaces such as elbows, knees, buttocks, and the sacrum. 2. Note that excoriations are frequently seen due to intense scratching, often masking intact primary vesicles.
9. VIVA TRAP: Can the presence of normal weight and height on standard growth charts completely exclude the diagnosis of celiac disease in a school-aged child?	NO. More than 60% of modern celiac presentations are atypical, presenting with isolated short stature, refractory iron deficiency anemia, or normal anthropometry without classic wasting or diarrhea.
10. How do you assess for clubbing or peripheral stigmata during general physical examination in a child evaluated for chronic diarrhea?	Inspect the fingernails for loss of the normal Lovibond angle (greater than 180 degrees), increased sponginess of the nail bed, and drumstick-like enlargement of the fingertips, which should raise suspicion for coexistent inflammatory bowel disease or cystic fibrosis rather than uncomplicated celiac disease.
11. What specific bedside physical signs help differentiate the abdominal distension of celiac disease from that caused by ascites?	1. Celiac distension is tympanitic on percussion throughout the anterior abdomen with a central gas pattern. 2. True ascites demonstrates shifting dullness and a fluid thrill, which are absent in uncomplicated celiac distension unless severe hypoalbuminemic decompensation has occurred.
12. What clinical examination maneuvers help detect occult tetany or neuromuscular hyperexcitability in a child presenting with celiac crisis?	1. Elicit Chvostek's sign by tapping the facial nerve anterior to the external acoustic meatus, observing ipsilateral facial muscle twitching. 2. Elicit Trousseau's sign by inflating a sphygmomanometer cuff above systolic pressure for 3 minutes, observing carpopedal spasm.
13. VIVA TRAP: Does the presence of generalized abdominal tenderness on light palpation confirm active mucosal inflammation in celiac disease?	NO. Uncomplicated celiac disease classically presents with a soft, non-tender, distended abdomen; significant localized or generalized tenderness suggests secondary complications such as a celiac crisis, bacterial overgrowth, or an alternative diagnosis like Crohn's disease.
14. What specific visual inspection findings in the perianal area help distinguish celiac disease from inflammatory bowel disease during physical examination?	The perianal area in celiac disease is typically clean and normal on inspection, whereas inflammatory bowel disease (Crohn's disease) characteristically exhibits perianal skin tags, deep fissures, fistulae, or macerated ulcerations.
15. How do you examine for delayed sexual maturation and pubertal delay during the systemic physical evaluation of an adolescent with untreated celiac disease?	Assess secondary sexual characteristics using Tanner staging (e.g., breast development and pubic hair in females, testicular volume using a Prader orchidometer and pubic hair in males) and document constitutional delay of growth and puberty.
16. VIVA TRAP: Is hepatomegaly a mandatory physical sign in classical celiac disease due to fatty infiltration or secondary malnutrition?	NONE. The liver is typically normal in size and non-palpable in uncomplicated celiac disease; palpable hepatomegaly should prompt investigation for celiac hepatitis, autoimmune liver disorders (such as autoimmune hepatitis or primary sclerosing cholangitis associated with celiac disease), or glycogen storage disorders.

Diagnostic Criteria & Investigations

Question	Answer
1. What is the primary serological screening test of choice for celiac disease in children aged 2 years and older?	Quantitative Serum IgA anti-tissue transglutaminase (anti-tTG IgA), because it offers the highest sensitivity and specificity among available serological markers.
2. Why is it mandatory to measure Total Serum IgA alongside anti-tTG IgA when screening a child for celiac disease?	Selective IgA deficiency occurs in approximately 1 in 40 celiac patients, which causes falsely negative anti-tTG IgA results and requires IgG-based testing.
3. What alternative serological tests must be ordered if a child with suspected celiac disease is found to have selective IgA deficiency?	IgG-based serology, specifically anti-Deamidated Gliadin Peptide IgG (anti-DGP IgG) or anti-tTG IgG.
4. What are the specific antibody cutoffs and conditions required for the ESPGHAN 2020 'No-Biopsy' diagnostic approach in children?	Anti-tTG IgA must be at least 10 times the upper limit of normal (≥10x ULN) on a first blood sample, and a second independent blood sample must confirm positivity for anti-Endomysial Antibodies (EMA IgA).
5. What is the gold standard invasive investigation for confirming celiac disease when serology is equivocal or does not meet the no-biopsy criteria?	Upper gastrointestinal endoscopy with multiple targeted biopsies from the duodenal bulb (at least one) and distal duodenum (at least four biopsies).
6. What are the classic histological findings on duodenal biopsy graded according to the Marsh-Oberhuber classification in active celiac disease?	Marsh 3 lesions, characterized by subtotal to total villous atrophy, crypt hyperplasia, and marked intraepithelial lymphocytosis (>25 intraepithelial lymphocytes per 100 enterocytes).
7. VIVA TRAP: Can a positive HLA-DQ2 or HLA-DQ8 genetic test alone establish a definitive diagnosis of celiac disease in a symptomatic child?	NO. Genetic testing indicates only genetic susceptibility, as up to 30% of the general population carries these alleles, whereas only 2-3% develop the disease.
8. How do you interpret anti-tTG IgA antibody titers when monitoring a diagnosed celiac child who has been placed on a strict gluten-free diet?	Antibody titers should drop by more than 50% within 3 to 6 months of initiating a gluten-free diet and normalize entirely by 12 months.
9. What specific radiological imaging findings are classically described on a barium swallow or follow-through study in untreated pediatric celiac disease?	Dilatation of the jejunal loops, moulage sign (loss of mucosal folds), flocculation and segmentation of barium, and reversal of the jejuno-ileal fold pattern.
10. What ultrasound or computed tomography findings may be observed in the abdomen of a child presenting with severe, complicated celiac disease?	Generalized bowel loop distension with fluid-filled lumen, transient intussusception secondary to hyperperistalsis, and occasionally enlarged mesenteric lymph nodes.
11. What primary laboratory abnormalities are typically uncovered on a complete blood count and iron panel in a child with atypical celiac disease?	Microcytic, hypochromic anemia reflecting iron deficiency refractory to oral iron supplementation, often accompanied by low serum ferritin and elevated total iron-binding capacity.
12. What serum biochemical parameters should be routinely evaluated at diagnosis to assess systemic complications and micronutrient deficiencies in celiac disease?	Serum calcium, inorganic phosphorus, alkaline phosphatase, total protein, albumin, liver function tests, and 25-hydroxyvitamin D3 levels.
13. VIVA TRAP: Does a negative anti-tTG IgA test in a child consuming a normal gluten-containing diet completely rule out celiac disease?	NO. It does not rule out celiac disease if the child has concurrent selective IgA deficiency, is on immunosuppressive therapy, or if the serology is falsely negative due to very young age (<2 years).
14. Why are anti-gliadin antibodies (AGA IgA and IgG) no longer recommended by ESPGHAN guidelines for the routine diagnosis of celiac disease?	They exhibit unacceptably low specificity and poor diagnostic accuracy compared to modern anti-tTG and anti-DGP assays.
15. What specialized diagnostic test is indicated when assessing bone mineral density and osteopenia/osteoporosis in an adolescent with chronic untreated celiac disease?	Dual-energy X-ray absorptiometry (DEXA) scan of the lumbar spine and total hip.
16. VIVA TRAP: If a child has been on a gluten-free diet for 3 weeks prior to consultation, can diagnostic serology and duodenal biopsy still reliably confirm celiac disease?	NEVER. Dietary gluten restriction prior to testing leads to rapid serological titer reduction and mucosal healing, causing false-negative diagnostic results (gluten challenge is required).
17. What specific blood gas and electrolyte abnormalities typify the biochemical profile of an infant presenting with an acute 'celiac crisis'?	Severe hypokalemia, hyponatremia, hypocalcemia, metabolic acidosis, and hypoalbuminemia reflecting profound third-space fluid loss and malabsorption.
18. What is the recommended frequency and choice of serological testing during long-term follow-up of a compliant child with established celiac disease?	Annual anti-tTG IgA testing combined with clinical evaluation for growth, dietary adherence, and associated autoimmune conditions.

Evidence-Based Management & Pharmacotherapy

Question	Answer
1. What are the strictly prohibited grains that must be completely eliminated from the diet of a child diagnosed with celiac disease?	1. Wheat and its derivatives (gliadin, spelt, semolina/suji, durum, maida). 2. Barley (hordein). 3. Rye (secalin). 4. Oats, unless specifically certified pure and uncontaminated (due to frequent cross-contamination and avenin content).
2. What specific safe grains and starchy staples can be freely included in a gluten-free diet for children?	1. Rice. 2. Maize (corn). 3. Millets (Ragi, Jowar, Bajra). 4. Quinoa, buckwheat (kuttu), amaranth (rajgira), sago (sabudana), soy, and potatoes.
3. What is a 'Celiac Crisis', and what are its life-threatening clinical manifestations?	1. A rare, severe, acute presentation typically triggered by an intercurrent GI infection. 2. Manifests with explosive watery diarrhea, profound dehydration, hypokalemic metabolic acidosis, severe hypoproteinemia/anasarca, and hypocalcemic tetany.
4. What is the immediate acute medical resuscitation protocol for managing an infant presenting with a celiac crisis?	1. Isotonic fluid resuscitation with 0.9% NaCl and aggressive correction of electrolyte imbalances, particularly hypokalemia and hypocalcemia. 2. Temporary parenteral nutrition (TPN) if catastrophic stool purges preclude oral feeding.
5. What specific drug class and dosage regimen are indicated to induce rapid clinical and mucosal recovery during a severe celiac crisis?	1. Systemic glucocorticoids. 2. Inj. Methylprednisolone at 1 to 2 mg/kg/day IV (or oral Prednisolone equivalent) administered for 1 to 2 weeks to suppress inflammation and restore brush-border enzyme function.
6. What is the recommended schedule for monitoring serological adherence using anti-tTG IgA titers following GFD initiation?	1. Check anti-tTG IgA at 3, 6, and 12 months post-GFD initiation, and subsequently on an annual basis. 2. Titers should drop by >50% within 3-6 months and normalize by 12 months in compliant children.
7. What clinical implication does a persistently elevated anti-tTG IgA titer at the 12-month follow-up visit carry?	1. It indicates ongoing, occult dietary gluten ingestion (intentional or accidental cross-contamination). 2. It warrants a formal dietitian review and environmental audit of the child's food sources.
8. What baseline nutritional and micronutrient supplements must be co-prescribed during the initial phase of celiac disease treatment?	1. Therapeutic iron supplementation (if iron deficiency anemia is present). 2. Elemental calcium and high-dose Vitamin D3. 3. Fat-soluble vitamin supplements (A, E, K) and multivitamins to correct malabsorptive deficits.
9. What specialized bone health screening investigation is recommended during long-term follow-up of adolescents with chronic celiac disease?	1. Dual-energy X-ray absorptiometry (DEXA) scan to evaluate bone mineral density. 2. Accompanied by biochemical surveillance of serum calcium, phosphorus, alkaline phosphatase, and 25-OH Vitamin D levels.
10. VIVA TRAP: Can oats be safely introduced into the diet of a newly diagnosed child with celiac disease immediately after starting treatment?	NEVER. Oats must be initially avoided; they can only be introduced later if they are certified pure and uncontaminated, and even then, only under medical and serological supervision since a subset of patients react to avenin.
11. What dietary hidden sources of gluten must parents be specifically cautioned about when counseling a family on a strict gluten-free diet?	1. Commercial sauces, soy sauce, and ketchups thickened with wheat starch. 2. Processed meats, sausages, and soups containing gluten fillers. 3. Medications, syrups, and asafetida (hing) compounded with wheat flour.
12. What is the mechanism of action of systemic glucocorticoids when used in the acute rescue therapy of a celiac crisis?	1. Potent anti-inflammatory and immunosuppressive action that rapidly blunts the mucosal immune response mediated by intraepithelial lymphocytes and lamina propria T-cells. 2. Accelerates enterocyte regeneration and crypt-villus architectural recovery.
13. How should oral iron supplementation be managed in a child with severe celiac disease and refractory iron deficiency anemia?	1. Prescribe oral elemental iron (3-5 mg/kg/day of elemental iron as ferrous salts). 2. Ensure concurrent strict adherence to a gluten-free diet, as ongoing mucosal damage impairs active iron absorption in the duodenum regardless of oral intake.
14. VIVA TRAP: Is there any approved pharmacotherapy (such as enzyme supplements or zonulin inhibitors) that allows a celiac child to occasionally consume gluten safely?	NONE. There are currently no approved pharmacological agents, digestive enzyme preparations, or polymers that reliably prevent gluten-induced mucosal damage; a lifelong, strict gluten-free diet remains the only proven therapy.
15. What specific dietary counseling approach should be implemented if a child fails to gain weight despite reporting strict adherence to a gluten-free diet?	1. Evaluate for inadvertent gluten contamination via shared kitchen utensils, condiments, or hidden processed food sources. 2. Screen for secondary conditions like small intestinal bacterial overgrowth (SIBO), lactose intolerance, or refractory celiac disease.
16. What supportive management is required for children presenting with severe hypocalcemic tetany secondary to vitamin D and calcium malabsorption in celiac disease?	1. Immediate slow intravenous infusion of calcium gluconate (100–200 mg/kg) under cardiac monitoring. 2. Subsequent initiation of high-dose oral elemental calcium and active or high-dose cholecalciferol supplementation.
17. When is parenteral nutrition (TPN) specifically indicated in the management spectrum of pediatric celiac disease?	1. Restricted strictly to catastrophic presentations like a severe celiac crisis with intractable vomiting and profuse watery diarrhea where enteral feeding causes severe fluid and electrolyte worsening.
18. VIVA TRAP: Can a gluten-free diet be safely relaxed once anti-tTG IgA antibodies completely normalize and mucosal healing is confirmed on follow-up biopsy?	NEVER. Celiac disease is a lifelong autoimmune enteropathy; relaxing the diet will invariably trigger a recurrence of mucosal atrophy, inflammation, and long-term complications.
19. What parameters should be monitored to ensure catch-up growth and nutritional recovery in children recovering from classical celiac disease?	1. Serial plotting of weight-for-age, height-for-age, and BMI percentiles on standardized growth charts at every follow-up visit. 2. Periodic assessment of hemoglobin, serum ferritin, total proteins, and lipid profile.
20. What environmental and psychological support strategies are essential for long-term successful management of an adolescent with celiac disease?	1. Formal referral to a specialized pediatric clinical dietitian for meal planning and label-reading education. 2. Peer support groups and counseling to address dietary restrictions, social isolation, and adherence fatigue during adolescence.

High-Yield VIVA TRAPs & Examiner Pitfalls

Question	Answer
1. VIVA TRAP: Can a celiac child safely consume commercially labeled "gluten-free" oat products immediately upon diagnosis?	NO. Newly diagnosed children should avoid oats initially until clinical stabilization and serological decline occur, because a subset of celiac patients react to the avenin protein in pure oats, and commercial oats carry a high risk of cross-contamination with wheat.
2. VIVA TRAP: Is it permissible to advise a gluten-free diet based solely on a positive family history of celiac disease in an asymptomatic sibling?	NEVER. A gluten-free diet must never be initiated without a confirmed diagnosis through proper serology and, if required, biopsy, because starting a GFD prematurely masks the disease and invalidates future diagnostic testing.
3. VIVA TRAP: Can a child who has been following a strict gluten-free diet for 6 months undergo a gluten challenge just to "double-check" the diagnosis if parents have doubts?	NO. A formal gluten challenge should only be performed under specialist supervision and is generally deferred until adolescence or adulthood unless the initial diagnosis was highly questionable; reintroducing gluten risks severe mucosal damage and symptom recurrence.
4. VIVA TRAP: If a 5-year-old child with classical celiac disease starts gaining weight rapidly after 1 month on a GFD, should you immediately stop monitoring their anti-tTG IgA titers?	NEVER. Clinical improvement and weight gain reflect symptom resolution, but serological monitoring with anti-tTG IgA at 3, 6, and 12 months is still mandatory to objectively confirm mucosal healing and dietary compliance.
5. VIVA TRAP: Are enzyme supplements containing prolyl endopeptidases considered a safe alternative substitute to a strict gluten-free diet during parties or dining out?	NONE. No currently available oral enzyme supplement, probiotic, or drug can reliably neutralize ingested gluten or prevent mucosal inflammation; a lifelong, strict gluten-free diet remains the only proven therapy.
6. VIVA TRAP: Can beer, malt beverages, and soy sauces flavored with hydrolyzed wheat protein be permitted in an adolescent's gluten-free diet if consumed in small quantities?	NEVER. Beer and standard malt beverages are brewed from barley, and traditional soy sauces commonly contain fermented wheat; even trace amounts will perpetuate mucosal injury in celiac disease.
7. VIVA TRAP: Can systemic corticosteroids be used as long-term maintenance therapy to control inflammation in patients with refractory celiac disease?	NEVER. Corticosteroids are restricted strictly to life-threatening acute rescue scenarios like a celiac crisis; using them for long-term maintenance carries severe side effects without replacing the necessity of a strict GFD.
8. VIVA TRAP: Is it safe to assume that a child with Down syndrome who is currently asymptomatic and growing well does not need periodic screening for celiac disease?	NO. High-risk groups like children with Down syndrome, Type 1 Diabetes, and Turner syndrome must undergo regular serological screening (anti-tTG IgA every 2-3 years) because celiac disease in these populations is frequently silent or atypical.
9. VIVA TRAP: Can a gluten-free diet be liberalized or discontinued once a repeat duodenal biopsy confirms complete mucosal recovery and Marsh 0 histology?	NEVER. Celiac disease is a lifelong immune-mediated enteropathy; liberalizing or discontinuing the gluten-free diet invariably leads to prompt histological relapse and recurrence of systemic complications.
10. VIVA TRAP: Should non-absorbable antacids or proton pump inhibitors be prescribed as first-line therapy for persistent abdominal distension in newly diagnosed celiac children?	NONE. Antacids and PPIs do not address the underlying gluten-induced enteropathy; flatulence and distension resolve exclusively through strict adherence to a gluten-free diet and correction of malabsorption.
11. VIVA TRAP: Can routine multivitamin and iron supplementation be safely omitted in a newly diagnosed celiac child if their hemoglobin level is within the normal range?	NO. Even with normal hemoglobin, children with active celiac disease frequently harbor occult deficiencies in iron stores, folate, vitamin D, and trace minerals due to proximal small bowel villous atrophy, necessitating initial supplementation.
12. VIVA TRAP: Is it appropriate to perform HLA-DQ2/DQ8 genetic testing on family members as a primary screening tool to diagnose active celiac disease?	NO. Genetic testing has an extremely high negative predictive value (ruling out celiac disease if negative), but it cannot diagnose active disease because nearly 30-40% of the general population carries these HLA alleles without ever developing enteropathy.
13. VIVA TRAP: Can parents rely solely on food labels marked "wheat-free" when purchasing packaged snacks for their celiac child?	NEVER. "Wheat-free" does not mean "gluten-free," as wheat-free products may still contain hidden gluten from barley, rye, or cross-contaminated oats; packages must explicitly state "Gluten-Free" or be certified.
14. VIVA TRAP: Can you confirm that a child has completely adhered to a gluten-free diet based solely on their verbal dietary history during an outpatient clinic visit?	NO. Patient and parental recall is notoriously unreliable; objective verification requires serial monitoring of falling anti-tTG IgA antibody titers alongside clinical and growth recovery.
15. VIVA TRAP: Are routine follow-up endoscopies and duodenal biopsies mandatory every year for all children successfully managed on a gluten-free diet?	NONE. Routine surveillance biopsies are not recommended for asymptomatic children whose anti-tTG IgA titers have normalized; endoscopy is reserved for those with refractory symptoms or unexplained clinical deterioration.
16. VIVA TRAP: Can cow's milk and dairy products be continued without restriction in an infant presenting with an acute, severe celiac crisis and chronic diarrhea?	NO. Secondary lactase deficiency is extremely common in severe celiac crisis due to brush-border destruction; a temporary lactose-free diet or formula should be instituted alongside GFD until mucosal recovery occurs.
17. VIVA TRAP: Can anti-DGP IgG antibodies be used as the primary initial screening test for an otherwise healthy 8-year-old child with normal total serum IgA?	NO. Anti-tTG IgA is the gold standard primary screening test for children over 2 years with normal IgA; anti-DGP IgG or tTG IgG are reserved specifically for children with documented selective IgA deficiency.
18. VIVA TRAP: Can a celiac child consume communion wafers, traditional soy sauce, or herbal medicines formulated with excipients derived from wheat starch if taken in minuscule ritual doses?	NEVER. There is no safe threshold or "micro-dose" of gluten for a patient with celiac disease; even minute quantities provoke immune-mediated crypt hyperplasia and intraepithelial lymphocytosis.